About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT02116686

ECG Derived Respiration for Automated Screening of Sleep Disordered Breathing in Chronic Heart Failure Patients

The prevalence of sleep disordered breathing (SDB) reaches more than 50% in chronic heart failure patients (CHF). The main consequence is an increase risk of fatal and non-fatal cardiovascular events....

Lead sponsor: Centre Hospitalier Universitaire de Saint Etienne•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Centre Hospitalier Universitaire de Saint Etienne

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•chronic heart failure
•left ventricular ejection fraction \< 45%
•New York Heart Association (NYHA) index ≥ 2
•Sleep apnea syndrom confirmed by polysomnography

Exclusion Criteria

•Chronic Obstructive Pulmonary Disease with maximal Respiratory Volume \< 50%
•Resting oxygen saturation \< 90%
•Continuous Positive Airway Pressure (CPAP) or Adaptive Servo-Ventilation treatment
•Life expectancy \< 1 year for other medical reasons than heart failure
•Cardiac surgery
•Percutaneous transluminal coronary angioplasty
•Unstable angora during the 6 last months
•Implantation of a pacemaker or a defibrillator during the 6 last months
•Cerebrovascular accident or Transient Ischemic Attack during the 3 last months
•Restless legs syndrome
•Acute myocarditis or pericarditis during the 6 last months
•Valvular disease
•Pregnancy

Related studies

MRI Assessment of Pulmonary Edema in Acute Heart Failure

NCT03999138 · Acute Heart Failure, Pulmonary Edema With Heart Failure

RECRUITINGPhase 2

CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation

NCT06762964 · Fontan Circulation, Single Ventricle Heart Disease, and more

Biomarker Guided Discharge of Heart Failure Patients

NCT03103932 · Heart Failure; With Decompensation

Assessing Systemic Circulation and LV Performance in Adults

NCT04347655 · Heart Failure

RECRUITINGPhase 2

A Study of 68Ga-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart Failure

NCT07083011 · Heart Failure With Preserved Ejection Fraction

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 31, 2015Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment100

Start dateJun 2013

Last updatedMar 31, 2015

Condition

Heart Failure Sleep Apnea Syndromes Polysomnography

Locations shown

CHU de Grenoble

Grenoble

CHU de Saint-Etienne

Saint-Etienne

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 31, 2015Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions